Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytodyn Inc (OP: CYDY )

0.1158 +0.0008 (+0.70%)
Streaming Delayed Price Updated: 3:59 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytodyn Inc

< Previous 1 2 3 4 Next >
These OTC Markets Securities had the Most Trading Activity in September
Photo by Annie Spratt on Unsplash As the 3rd quarter came to a close in September, the OTC Markets saw a slight decrease in total trading volume even as companies reported... 
Via Benzinga
CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan”
From CytoDyn Inc.
Via Business Wire
Group of CytoDyn Stockholders Releases White Paper Regarding Company’s Extremely Unfavorable Borrowing Practices
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A
From CytoDyn Inc.
Via Business Wire
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
Via FinancialNewsMedia
Exposures COVID-19
CytoDyn Receives Clearance from Brazil’s FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)
From CytoDyn Inc.
Via Business Wire
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021
From CytoDyn Inc.
Via Business Wire
Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group
From CytoDyn Inc.
Via Business Wire
Bruce Patterson, M.D., Director Candidate for CytoDyn Board, Presents at International COVID Summit
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
Glancy Prongay & Murray LLP Announces Investigation of CytoDyn Inc.
From Glancy Prongay & Murray LLP
Via Business Wire
Group of CytoDyn Stockolders Responds to Misleading Company News Release
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
CytoDyn Highlights Court Ordering Rosenbaum/Patterson Group to Comply With the Federal Securities Laws
From CytoDyn Inc.
Via Business Wire
Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients
Via FinancialNewsMedia
Exposures COVID-19
Group of CytoDyn Stockholders Warns Stockholders of Board’s Continued Value Destruction and Failures
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
Group of CytoDyn Stockholders Files Lawsuit to Force Company to Allow Stockholders to Vote for Alternative Director Nominees
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
CytoDyn Urges Shareholders to Ignore Proxy Cards from Rosenbaum/Patterson Group
From CytoDyn
Via Business Wire
Group of CytoDyn Stockholders Responds to Highly Misleading Company Release
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
CytoDyn Provides Update on Rosenbaum/Patterson Group Litigation
From CytoDyn Inc.
Via Business Wire
CytoDyn Files Lawsuit Against Rosenbaum/Patterson Activist Group for Misleading Shareholders and Waging an Unlawful Proxy Contest
From CytoDyn Inc.
Via Business Wire
CytoDyn Receives Clearance from Brazil’s ANVISA to Commence Phase 3 Trial for Severe COVID-19 Patients
From CytoDyn Inc.
Via Business Wire
CytoDyn Announces That Director Nominations by Rosenbaum/Patterson Activist Group Are Invalid
From CytoDyn Inc.
Via Business Wire
CytoDyn Inc. (OTC: CYDY) Long Term Investor Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 07/28/2021 -- An investigation on behalf of current long term investors in CytoDyn Inc. (OTC: CYDY) shares over possible breaches of fiduciary duty by certain officers and... 
Via SBWire
Topics Lawsuit
Exposures COVID-19 Financial Legal
OTC Markets Hits Major Milestones in Mid-Year Along With Big Volume and Gaining Securities
Photo by Kyrie Kim on Unsplash In a similar vein to 2020, the market’s volatility to start 2021 gave way to less volatility in the second quarter, and even less volatility... 
Via Benzinga
Group of Cytodyn Stockholders Nominates Five Highly Qualified Director Candidates to Replace Board Responsible for Mismanagement and Value Destruction
From Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via Business Wire
What's Behind This Wild-Card Coronavirus Stock?
Failure is not an option for this small-cap biotech developing a COVID-19 treatment. 
Via The Motley Fool
Exposures COVID-19
CytoDyn Plans To Send Topline Data From COVID-19 Trial Of Leronlimab To Regulators In India, Philippines
After facing rebuke from FDA, CytoDyn Inc (OTC: CYDY) plans to submit the topline results of its CD12 Phase 3 trial of Vyrologix (leronlimab-PRO 140... 
Via Benzinga
Exposures COVID-19 Product Safety
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.